Industry
Biotechnology
Fresh2 Group Limited, a biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests using cancer differentiation analysis technology and device to corporations and life insurance companies in the People's Republic of China. It also offers physical checkup packages, as well as technology services comprising market research, designing, coding, developing, testing, etc. In addition, the company sells genetic testing kits and skin-care products; and owns core technology platforms, as well as engages in technology development and product distribution. Further, it operates an e-commerce platform that connects food suppliers and supermarket operators and restaurant owners. The company was formerly known as AnPac Bio-Medical Science Co., Ltd. and changed its name to Fresh2 Group Limited in April 2023. The company was incorporated in 2010 and is based in New York, New York.
Loading...
Open
1.24
Mkt cap
1.9M
Volume
22K
High
1.49
P/E Ratio
-0.02
52-wk high
9.03
Low
1.22
Div yield
N/A
52-wk low
0.85
Portfolio Pulse from Benzinga Insights
November 01, 2024 | 8:36 pm
Portfolio Pulse from Benzinga Newsdesk
October 17, 2024 | 8:07 pm
Portfolio Pulse from Avi Kapoor
September 24, 2024 | 9:40 am
Portfolio Pulse from Benzinga Newsdesk
August 22, 2024 | 8:18 pm
Portfolio Pulse from Benzinga Newsdesk
July 16, 2024 | 1:28 pm
Portfolio Pulse from Benzinga Newsdesk
June 24, 2024 | 9:16 pm
Portfolio Pulse from Benzinga Insights
June 17, 2024 | 8:31 pm
Portfolio Pulse from Avi Kapoor
June 06, 2024 | 5:39 pm
Portfolio Pulse from Benzinga Insights
June 06, 2024 | 4:31 pm
Portfolio Pulse from Avi Kapoor
June 06, 2024 | 12:16 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.